Resolve to Present Data on Lupus Studies at International Rheumatology Conference
Resolve to Present Data on Lupus Studies at International Rheumatology Conference
Resolve Announces Positive Clinical Data from RSLV-132 Lupus Study
Resolve Announces Positive Clinical Data from RSLV-132 Lupus Study
Resolve Initiates RSLV-132 Clinical Studies
Resolve Initiates RSLV-132 Clinical Studies
Takeda and Resolve Therapeutics Enter Autoimmune Partnership
Takeda and Resolve Therapeutics Enter Autoimmune Partnership
Resolve Therapeutics Raises $5.8 Million in Private Financing
Resolve Therapeutics Raises $5.8 Million in Private Financing
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired
Resolve Announces Series A Financing, New Board Members
Resolve Announces Series A Financing, New Board Members
Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A
Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A
Resolve and UW Enter Agreement
Resolve and UW Enter Agreement
Resolve featured in Xconomy
Resolve featured in Xconomy